93 related articles for article (PubMed ID: 22504556)
1. Cell-to-cell contact of activated mast cells with fibroblasts and lymphocytes in systemic sclerosis.
Hügle T; White K; van Laar JM
Ann Rheum Dis; 2012 Sep; 71(9):1582. PubMed ID: 22504556
[No Abstract] [Full Text] [Related]
2. Interaction between mast cells and perineurial fibroblasts in neurofibroma. New insights into mast cell function.
Kirkpatrick CJ; Curry A
Pathol Res Pract; 1988 Aug; 183(4):453-61. PubMed ID: 3186546
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructure of cutaneous cellular infiltrates in scleroderma.
Fleischmajer R; Perlish JS; West WP
Arch Dermatol; 1977 Dec; 113(12):1661-6. PubMed ID: 202203
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody to gp50, a glycoprotein shared in common between fibroblasts and lymphocytes, in progressive systemic sclerosis.
Alderuccio F; Witherden D; Toh BH; Barnett A
Clin Exp Immunol; 1989 Oct; 78(1):26-30. PubMed ID: 2805420
[TBL] [Abstract][Full Text] [Related]
7. T cell-induced mast cell activation: a role for microparticles released from activated T cells.
Shefler I; Salamon P; Reshef T; Mor A; Mekori YA
J Immunol; 2010 Oct; 185(7):4206-12. PubMed ID: 20810987
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the growth rate of mouse fibroblasts by IL-3-activated mouse bone marrow-derived mast cells.
Dayton ET; Caulfield JP; Hein A; Austen KF; Stevens RL
J Immunol; 1989 Jun; 142(12):4307-13. PubMed ID: 2786027
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?
De Palma R; D'Aiuto E; Vettori S; Cuoppolo P; Abbate G; Valentini G
Rheumatology (Oxford); 2010 Jul; 49(7):1257-66. PubMed ID: 20418226
[TBL] [Abstract][Full Text] [Related]
10. Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts.
Chizzolini C; Parel Y; Scheja A; Dayer JM
Arthritis Res Ther; 2006; 8(1):R10. PubMed ID: 16356198
[TBL] [Abstract][Full Text] [Related]
11. Vgamma9+ gammadelta T cells in systemic sclerosis patients are numerically and functionally preserved and induce fibroblast apoptosis.
Bendersky A; Markovits N; Bank I
Immunobiology; 2010 May; 215(5):380-94. PubMed ID: 19589616
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of progressive systemic sclerosis.
Postlethwaite AE; Kang AH
J Lab Clin Med; 1984 Apr; 103(4):506-10. PubMed ID: 6607964
[No Abstract] [Full Text] [Related]
13. Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro.
Brill A; Baram D; Sela U; Salamon P; Mekori YA; Hershkoviz R
Clin Exp Allergy; 2004 Nov; 34(11):1725-31. PubMed ID: 15544597
[TBL] [Abstract][Full Text] [Related]
14. T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.
Chizzolini C
Springer Semin Immunopathol; 1999; 21(4):431-50. PubMed ID: 10945035
[No Abstract] [Full Text] [Related]
15. Mast cell adhesion induces cytoskeletal modifications and programmed cell death in oligodendrocytes.
Medic N; Lorenzon P; Vita F; Trevisan E; Marchioli A; Soranzo MR; Fabbretti E; Zabucchi G
J Neuroimmunol; 2010 Jan; 218(1-2):57-66. PubMed ID: 19906445
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation.
Yoshizaki A; Yanaba K; Iwata Y; Komura K; Ogawa A; Muroi E; Ogawa F; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
Ann Rheum Dis; 2011 Jan; 70(1):194-200. PubMed ID: 20705635
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity to extracellular ATP of fibroblasts from patients affected by systemic sclerosis.
Lo Monaco A; Gulinelli S; Castellino G; Solini A; Ferrari D; La Corte R; Trotta F; Di Virgilio F
Ann Rheum Dis; 2007 Aug; 66(8):1124-5. PubMed ID: 17626974
[No Abstract] [Full Text] [Related]
18. Ultrastructural evidence for mast cell activation in a case of neurofibromatosis.
Giorno R; Lieber J; Claman HN
Neurofibromatosis; 1989; 2(1):35-41. PubMed ID: 2517021
[TBL] [Abstract][Full Text] [Related]
19. Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions.
Frossi B; D'Incà F; Crivellato E; Sibilano R; Gri G; Mongillo M; Danelli L; Maggi L; Pucillo CE
Eur J Immunol; 2011 Jul; 41(7):1872-82. PubMed ID: 21509780
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis. The role of the mast cell and cytokines.
Frieri M
Ann Allergy; 1992 Nov; 69(5):385-92, 395-6. PubMed ID: 1456480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
